A team at Purdue Univ. has used gold nanoparticles to target and bind to fragments of genetic material known as BRCA1 messenger RNA splice variants, which can indicate the presence and stage of breast cancer. The number of these synthetic DNA “tails” in a cell can be determined in a living cell by examining the specific signal that light produces when it interacts with the gold nanoparticles.
Unlike healthy cells, cancer cells thrive when deprived of oxygen. Tumors in low-oxygen...
A credit-card-sized anthrax detection cartridge developed at Sandia National Laboratories and...
Researchers have discovered that the so-called...
In the fictional Star-Trek universe, the tricorder was used to remotely scan patients for a diagnosis. A new device under development in the U.K. could perform that function through the use of chemical sensors on printed circuit boards. This would replace the current conventional diagnostic method, which is lengthy and is limited to single point measurements.
Call it “homo minutus”. A team at Los Alamos National Laboratory is developing four human organ constructs (liver, heart, lung and kidney) that will work together to serve as a drug and toxicity analysis system that can mimic the actual response of human organs. Called ATHENA, for Advanced Tissue-engineered Human Ectypal Network Analyzer, the system will fit neatly on a desk.
A new microfluidic method for evaluating drugs commonly used for preventing heart attacks has found that while aspirin can prevent dangerous blood clots in some at-risk patients, it may not be effective in all patients with narrowed arteries. The study, a first in the examination of heart attack prevention drugs, used a device that simulated blood flowing through narrowed coronary arteries to assess effects of anti-clotting drugs.
It's a jungle in there. In the tightly woven ecosystem of the human gut, trillions of bacteria compete with each other on a daily basis while they sense and react to signals from the immune system, ingested food and other bacteria. Problems arise when bad gut bugs overtake friendly ones, or when the immune system is thrown off balance.
Smartphones are capable of giving us directions when we’re lost, sending photos and videos to our friends in mere seconds and, perhaps very soon, diagnose our diseases in real time. Researchers in Texas are developing a disease diagnostic system made of a glass slide and a porous film of gold that offers results that could be read using only a smartphone and a $20 lens attachment.
Ever since the study of individual genes and RNAs was first known to be important, there has been a drive to get as detailed and complete genomic information as possible. Early technologies like the hybridization-based Southern and Northern blotting methods were tremendous advances, but allowed only a handful of genomic targets to be studied at a time.
When a person becomes sick or is exposed to an unwelcome substance, the body mobilizes specific proportions of different immune cells in the blood. Methods of discovering and detecting those profiles are therefore useful both clinically and in research. In a new Genome Biology paper, a team of scientists describes a new and uniquely advantageous way to detect them.
About the size of a stapler, this new handheld device developed in Switzerland is able to test a large number of proteins in our body all at once. This optical “lab on a chip” is compact and inexpensive, and it could offer the possibility of quickly analyzing up to 170,000 different molecules in a blood sample.
Finding treatments for advanced stage cancer isn’t easy. Therefore, early detection methods are paramount in the fight against the disease. Motivated by the opportunity to intervene as early as possible in the course of cancer, Dr. Muneesh Tewari, a Univ. of Michigan researcher, has been studying the diagnostic potential of blood-based biomarkers.
Before doctors like Matthias Kretzler can begin using the results of molecular research to treat patients, they need science to find an effective way to match genes with the specific cells involved in disease. As Kretzler explains, finding that link would eventually let physicians create far more effective diagnostic tools and treatments.
A DNA test of a pregnant woman's blood is more accurate than current methods of screening for Down syndrome and other common disorders, new research finds. If other studies bear this out, it could transform prenatal care by giving a more reliable, non-invasive way to detect these problems very early in pregnancy.
From the sun, a solution: Cornell Univ. and Weill Cornell Medical College researchers have remodeled an energy-intensive medical test, designed to detect a deadly skin cancer related to HIV infections, to create a quick diagnostic assay perfect for remote regions of the world. By harnessing the sun’s power and employing a smartphone application, medical technicians may now handily administer reliable assays for Kaposi’s sarcoma.
A saliva test for teenage boys with mild symptoms of depression could help identify those who will later develop major depression, a new study says. Researchers measured the stress hormone cortisol in teenage boys and found that ones with high levels coupled with mild depression symptoms were up to 14 times more likely to suffer clinical depression later in life than those with low or normal cortisol levels.
Purdue Univ. researchers have developed a laser sensor that can identify Salmonella bacteria grown from food samples about three times faster than conventional detection methods. Known as BARDOT, the machine scans bacteria colonies and generates a distinct black and white "fingerprint" by which they can be identified. BARDOT takes less than 24 hrs to pinpoint Salmonella.
The U.S. and 26 other countries began a new effort Thursday to prevent and fight outbreaks of dangerous infectious diseases before they spread around the globe. U.S. health officials called the Global Health Security Agenda a priority because too many countries lack the health infrastructure necessary to spot a new infection rapidly and sound the alarm before it has time to gain a foothold and even spread into other countries.
A one-letter change in the human genetic code can sometimes mean the difference between health and a serious disease. But replicating these tiny changes in human stem cells has proven challenging. Scientists at the Gladstone Institutes have found a way to efficiently edit the human genome one letter at a time, not only boosting researchers' ability to model human disease, but also paving the way for new therapies.
If you're unlucky enough to be stricken with a rare medical condition, you'd better hope your doctor watches the right television show. That was the lesson for one German man with severe heart failure and a puzzling mix of symptoms including fever, blindness, deafness and enlarged lymph nodes, which baffled doctors for months.
Pancreatic cancer is a particularly devastating disease. At least 94% of patients will die within five years, and in 2013 it was ranked as one of the top 10 deadliest cancers. Routine screenings for breast, colon and lung cancers have improved treatment and outcomes for patients with these diseases. But because little is known about how pancreatic cancer behaves, patients often receive a diagnosis when it’s already too late.
Progress often requires change. For protein-based diagnostics, multiplexed assays and detection of protein isoforms will drive the adoption of a new strategy for diagnostic testing, called immuno-MS. Enzyme-linked immunosorbent assays (ELISA) have become the standard for antibody-based diagnostic tests in clinical settings. ELISAs provide specific detection of biomarkers through use of antibodies which target specific epitopes on antigens.
Medical laboratory test results provide physicians with vital information needed for accurate diagnosis, treatment and monitoring of patients. An estimated 60 to 70% of all decisions regarding a patient’s diagnosis and treatment, hospital admission and discharge are based on laboratory test results.
Nearly 70% of patients with advanced breast cancer experience skeletal metastasis, in which cancer cells migrate from a primary tumor into bone. While scientists are attempting to better understand metastasis in general, not much is known about how and why certain cancers spread to specific organs. Now researchers have developed a 3-D microfluidic platform that mimics the spread of breast cancer cells into a bone-like environment.
Designing nanomedicine to combat diseases is a hot area of scientific research, primarily for treating cancer, but very little is known in the context of atherosclerotic disease. Scientists have engineered a microchip coated with blood vessel cells to learn more about the conditions under which nanoparticles accumulate in the plaque-filled arteries of patients with atherosclerosis, the underlying cause of myocardial infarction and stroke.
Chances are you won’t know you’ve got a staph infection until the test results come in, days after the symptoms first appear. But what if your physician could identify the infection much more quickly and without having to take a biopsy and ship it off for analysis? Researchers at the Univ. of Iowa may have found a way.
Researchers at NIST and in Lithuania have used a NIST-developed laboratory model of a simplified cell membrane to accurately detect and measure a protein associated with a serious gynecological disease, bacterial vaginosis (BV), at extraordinarily low concentrations. The work illustrates how the artificial membrane could be used to improve disease diagnosis.
By letting DNA strands grow together with gold, scientists in Finland have developed a new concept for super-sensitive disease diagnostics. The method relies on growth of a DNA strand over a narrow gap between two electrodes in an electric circuit. The strand will only grow if a certain DNA molecule has bound to the surface of one electrode, which makes it possible to build diagnostic tests for detection of that specific DNA molecule.
- Page 1